MrMed
(EAZYMED TECHNOLOGIES PRIVATE LIMITED)
Founded in 2020
About MrMed
MrMed is an online pharmacy that delivers life saving medications. The startup offers prescribed and generic medicines for cancer, rheumatology, kidney disease, heart disorders, osteoporosis, and HIV. Also, it offers patient centric services that help in the procurement of medicines and adherence to patient assistance programmes.
Public Links of MrMed
Frequently Asked Questions (FAQ)
When was MrMed founded?
MrMed was founded in the year 2020.
What is the legal name of MrMed?
The legal name of MrMed is Eazymed Technologies Private Limited.
Who are the founders of MrMed?
MrMed is founded by Devashish Singh, Saurab Jain and Tejashwin Kameshwara Adiga.
Which VC Investors & Angel Networks funded MrMed?
What are the focus areas of MrMed?
Who are MrMed's competitors?
Possible competitors of MrMed may include Apex Kidney Care, Callthedoc Healthcare Solutions Private Limited, Canosis Pvt Healthcare Ltd and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
